ASCO 2016: Double Stem-Cell Transplant Improves Outcomes for Children with High-Risk Neuroblastoma
Historically, less than 50% of children with high-risk neuroblastoma live five or more years after…
Author ONA Editor
ONA Editor
The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.
ASCO 2016: Mediterranean diet may help stop breast cancer coming back, study says
By Sarah Boseley – The Guardian. Out of 199 women asked to eat lots of…
ASCO 2016: Cancer diagnosed more often in patients with primary immunodeficiency diseases
Primary immunodeficiency disorders are a group of more than 300 single gene defects that affect…
Saturated fatty acids linked to breast cancer in postmenopausal women
Fatty acids in the breast may be useful indicators of cancer in postmenopausal women, according…
More effective and less invasive: how breast cancer treatment has evolved since the 1950s
Nicholas Wilcken, University of Sydney. Treating breast cancer with a very high dose of chemotherapy…
Learning the language of cells will help scientists beat cancer
By Mohan Harihar, University of Leicester. Chemotherapy is a blunt weapon. It kills cancer cells…
ASCO 2016: Twice a day radiotherapy halves treatment time and is equally good at treating small cell lung cancer
Having radiotherapy once a day for six and a half weeks or twice a day…
ASCO 2016: Chemotherapy combination with capecitabine extends survival after pancreatic cancer surgery
A European phase III trial, one of the largest ever conducted in pancreatic cancer, showed…
ASCO 2016: Mobile-friendly web application extends lung cancer survival
A Web-mediated follow-up application (MoovcareTM) improves advanced lung cancer survival, according to a French multicentre randomised phase…
ASCO 2016: Cancer drug retail prices vastly different between countries
A pilot study revealed large differences in median retail prices for 23 cancer drugs in…